naltrexone has been researched along with Marijuana Abuse in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 6 (66.67) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Kebir, O; Laqueille, X; Mouaffak, F | 1 |
| Brooks, DJ; Choi, CJ; Kelly, MA; Levin, FR; Mahony, AL; Mariani, JJ; Notzon, DP; Pavlicova, M | 1 |
| Firoz, K; Manoj Kumar, G; Nidheesh Sankar, V; Raghuram, TM; Rajmohan, V | 1 |
| Batki, SL; Dimmock, JA; Leontieva, L; Ploutz-Snyder, R | 1 |
| Cooper, ZD; Haney, M | 1 |
| Gorelick, DA; Mannelli, P; Pae, CU; Patkar, AA; Peindl, K; Wu, LT | 1 |
| Braley, G; Carbuto, M; D'Souza, DC; Elander, J; Perry, E; Pittman, B; Radhakrishnan, R; Ranganathan, M; Sewell, RA | 1 |
| Bodnik, D; Dannon, P; Kotler, M; Rosenberg, O; Shoenfeld, N | 1 |
| McGeary, JE; Miranda, R; Monti, PM; Rohsenow, DJ | 1 |
4 trial(s) available for naltrexone and Marijuana Abuse
| Article | Year |
|---|---|
Opioid antagonism enhances marijuana's effects in heavy marijuana smokers.
Topics: Adult; Dose-Response Relationship, Drug; Double-Blind Method; Dronabinol; Drug Interactions; Female; Heart Rate; Humans; Male; Marijuana Abuse; Marijuana Smoking; Naltrexone; Narcotic Antagonists; Psychomotor Performance | 2010 |
Naltrexone does not attenuate the effects of intravenous Δ9-tetrahydrocannabinol in healthy humans.
Topics: Adolescent; Adult; Attention; Behavior; Cognition; Cognition Disorders; Double-Blind Method; Dronabinol; Drug Interactions; Euphoria; Female; Hallucinogens; Humans; Inhibition, Psychological; Injections, Intravenous; Male; Marijuana Abuse; Memory; Mental Recall; Middle Aged; Naltrexone; Narcotic Antagonists; Orientation; Perception; Psychoses, Substance-Induced; Recognition, Psychology; Reward; Young Adult | 2012 |
[Six-month follow-up study of drug treatment for cannabis addiction: comparison study of four drugs].
Topics: Adult; Bromazepam; Bupropion; Citalopram; Dopamine Uptake Inhibitors; Follow-Up Studies; GABA Modulators; Humans; Marijuana Abuse; Middle Aged; Naltrexone; Narcotic Antagonists; Patient Dropouts; Selective Serotonin Reuptake Inhibitors; Surveys and Questionnaires; Treatment Outcome; Young Adult | 2011 |
Family history and antisocial traits moderate naltrexone's effects on heavy drinking in alcoholics.
Topics: Adult; Age of Onset; Alcohol Drinking; Alcoholism; Antisocial Personality Disorder; Cocaine-Related Disorders; Comorbidity; Double-Blind Method; Family; Female; Genetic Predisposition to Disease; Humans; Male; Marijuana Abuse; Naltrexone | 2007 |
5 other study(ies) available for naltrexone and Marijuana Abuse
| Article | Year |
|---|---|
Mu-opioid antagonism in the treatment of cannabis use disorder
Topics: Craving; Dose-Response Relationship, Drug; Humans; Male; Marijuana Abuse; Middle Aged; Naltrexone; Narcotic Antagonists; Receptors, Opioid, mu; Recurrence; Substance Withdrawal Syndrome | 2020 |
Open-label pilot study of injectable naltrexone for cannabis dependence.
Topics: Adult; Female; Humans; Injections, Intramuscular; Male; Marijuana Abuse; Middle Aged; Naltrexone; Narcotic Antagonists; Pilot Projects; Treatment Outcome | 2018 |
Treatment of fetishism with naltrexone: a case report.
Topics: Adult; Alcoholism; Fetishism, Psychiatric; Humans; Male; Marijuana Abuse; Naltrexone; Treatment Outcome | 2014 |
Negative symptoms are associated with less alcohol use, craving, and "high" in alcohol dependent patients with schizophrenia.
Topics: Adult; Alcohol Drinking; Alcoholism; Behavior, Addictive; Cocaine-Related Disorders; Cognition Disorders; Comorbidity; Diagnostic and Statistical Manual of Mental Disorders; Euphoria; Female; Humans; Male; Marijuana Abuse; Naltrexone; Narcotic Antagonists; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Severity of Illness Index | 2008 |
Reduced cannabis use after low-dose naltrexone addition to opioid detoxification.
Topics: Dose-Response Relationship, Drug; Follow-Up Studies; Humans; Logistic Models; Marijuana Abuse; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Randomized Controlled Trials as Topic | 2010 |